Happy Planet Podcast

Happy Planet Podcast

风险投资与私募股权管理人

Biddeford Pool,Maine 118 位关注者

Telling Stories and Investment in Innovation for a Happy Planet

关于我们

Happy Planet Podcast amplifies stories of business innovation for a Happy Planet. Our investment arm provides seed investment, business support, and advisement to founders in the US and Europe with problem-solving technology ventures that make our planet and its people happier and healthier. Follow the podcast wherever you listen or though our website: happyplanetpodcast.com

网站
www.happyplanetpodcast.com
所属行业
风险投资与私募股权管理人
规模
1 人
总部
Biddeford Pool,Maine
类型
自有
创立
2022
领域
Blue Tech、Board Member、Seed Investment、France和US

地点

Happy Planet Podcast员工

动态

  • 查看Happy Planet Podcast的公司主页,图片

    118 位关注者

    RIP Renewcell. The fashion industry is?the?third most polluting industry?and produces about 10% of our annual carbon footprint.?Much of this is the fault of fast fashion where cheap, effectively disposable, clothes are the norm. But at every stage of the process, there are key issues that need to be cleaned up. The path to sustainability in this $1.7 trillion industry will be an uphill battle, and will likely play out as more of an?evolution?than a revolution.

    查看Abigail CARROLL的档案,图片

    Host of Happy Planet podcast. Public Speaker (TEDx, Boston Athenaeum, WHOI, GMRI, Island Institute…), Early-Stage Investor, Corporate Board Member, and Business Advisor working in US, France and UK.

    RIP Renewcell. The fashion industry is?the?third most polluting industry?and produces about 10% of our annual carbon footprint.?Much of this is the fault of fast fashion where cheap, effectively disposable, clothes are the norm. But at every stage of the process, there are key issues that need to be cleaned up. The path to sustainability in this $1.7 trillion industry will be an uphill battle, and will likely play out as more of an?evolution?than a revolution....

    This Startup Promised to Help Fashion Go Green. Brands Didn’t Want to Pay for It.

    This Startup Promised to Help Fashion Go Green. Brands Didn’t Want to Pay for It.

    wsj.com

  • 查看Happy Planet Podcast的公司主页,图片

    118 位关注者

    查看Aidan Petrie的档案,图片

    Healthcare Innovator, strategist and mentor.

    MedTech Startups Fail Because They Seem Easy (Part 1) As a seasoned entrepreneur and investor in the realm of medical technology, I've witnessed firsthand the challenges and triumphs of countless startups in this dynamic field. It's no secret that MedTech startups face some of the highest failure rates across all industries. Today, I want to delve into why this is the case. 1. The "Easy to Understand" Trap MedTech innovations often deal with tangible solutions applied to the intricacies of the human body. They involve plumbing, carpentry, and sometimes, sophisticated sensors and switches. While this accessibility can attract investors, it also creates a deceptive sense of simplicity that overlooks the complexities of bringing a product to market. 2. Familiarity Breeds Investment Investors are naturally drawn to concepts they can easily grasp. Unfortunately, this means that MedTech startups, with their straightforward narratives, may receive funding prematurely before the full extent of market challenges is understood. 3. Regulatory Hurdles: A Double-Edged Sword While navigating FDA regulations can be daunting, it's often viewed as a surmountable obstacle and the paramount achievement of development success. This false sense of security can lead to a complacency that neglects other critical aspects of business development or steps that need to be taken past clearance. 4. Oversized Market Opportunities The promise of a vast, transformative market can be intoxicating. Yet, it's essential to recognize that market potential alone does not guarantee success. Without a robust strategy for market entry and adoption, startups may find themselves struggling to make headway after launch.. 5. Founder Backgrounds Many MedTech CEOs hail from scientific, medical, or engineering backgrounds, bringing invaluable expertise to the table. However, this expertise doesn't always translate seamlessly into commercial acumen, and an understanding of marketing and sales, leading to challenges in scaling and sustaining the business. 6. The Transition from Development to Commercialization Perhaps the most critical juncture lies in the transition from product development to commercialization. This shift requires a fundamental change in mindset and skill set—a shift that not all CEOs are equipped to make. At NEMIC (New England Medical Innovation Center), we recognize the multifaceted nature of MedTech entrepreneurship. Our approach to company evaluation and our comprehensive education programs are designed to address both the apparent and underlying challenges, mitigating the risk of failure. Stay tuned for Part 2, where we'll delve deeper into strategies for navigating the complexities of the MedTech landscape. P.S. While these observations may seem like sweeping generalizations, they underscore the need for a nuanced understanding of the factors influencing MedTech startup success. #MedTech #Entrepreneurship #Innovation #StartupSuccess #NEMIC

相似主页